51 related articles for article (PubMed ID: 9484815)
1. Inhibition by xiao-chai-hu-tang (TJ-9) of development of hepatic foci induced by N-nitrosomorpholine in Sprague-Dawley rats.
Tatsuta M; Iishi H; Baba M; Nakaizumi A; Uehara H
Jpn J Cancer Res; 1991 Sep; 82(9):987-92. PubMed ID: 1682293
[TBL] [Abstract][Full Text] [Related]
2.
Sabu A; J S; R G; E D
Bioinformation; 2023; 19(1):43-47. PubMed ID: 37720282
[TBL] [Abstract][Full Text] [Related]
3. Antitumor Effects and Mechanisms of Metabolic Syndrome Medications on Hepatocellular Carcinoma.
Oura K; Morishita A; Tani J; Masaki T
J Hepatocell Carcinoma; 2022; 9():1279-1298. PubMed ID: 36545268
[TBL] [Abstract][Full Text] [Related]
4. Statin Use Decreases the Incidence of Hepatocellular Carcinoma: An Updated Meta-Analysis.
Facciorusso A; Abd El Aziz MA; Singh S; Pusceddu S; Milione M; Giacomelli L; Sacco R
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32260179
[TBL] [Abstract][Full Text] [Related]
5. Combination Therapy of Metformin and Statin May Decrease Hepatocellular Carcinoma Among Diabetic Patients in Asia.
Chen HH; Lin MC; Muo CH; Yeh SY; Sung FC; Kao CH
Medicine (Baltimore); 2015 Jun; 94(24):e1013. PubMed ID: 26091447
[TBL] [Abstract][Full Text] [Related]
6. Melatonin potentiates the anti-tumour effect of pravastatin in rat mammary gland carcinoma model.
Orendáš P; Kubatka P; Bojková B; Kassayová M; Kajo K; Výbohová D; Kružliak P; Péč M; Adamkov M; Kapinová A; Adamicová K; Sadloňová V; Chmelová M; Stollárová N
Int J Exp Pathol; 2014 Dec; 95(6):401-10. PubMed ID: 25270735
[TBL] [Abstract][Full Text] [Related]
7. Combination of 13-Cis retinoic acid and lovastatin: marked antitumor potential in vivo in a pheochromocytoma allograft model in female athymic nude mice.
Nölting S; Giubellino A; Tayem Y; Young K; Lauseker M; Bullova P; Schovanek J; Anver M; Fliedner S; Korbonits M; Göke B; Vlotides G; Grossman A; Pacak K
Endocrinology; 2014 Jul; 155(7):2377-90. PubMed ID: 24762141
[TBL] [Abstract][Full Text] [Related]
8. Pravastatin inhibits cell proliferation and increased MAT1A expression in hepatocarcinoma cells and in vivo models.
Hijona E; Banales JM; Hijona L; Medina JF; Arenas J; Herreros-Villanueva M; Aldazabal P; Bujanda L
Cancer Cell Int; 2012 Feb; 12():5. PubMed ID: 22353776
[TBL] [Abstract][Full Text] [Related]
9. The role of statins in neurosurgery.
Tapia-Pérez JH; Sanchez-Aguilar M; Schneider T
Neurosurg Rev; 2010 Jul; 33(3):259-70; discussion 270. PubMed ID: 20429022
[TBL] [Abstract][Full Text] [Related]
10. Inhibition by somatostatin of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.
Nakaizumi A; Uehara H; Baba M; Iishi H; Tatsuta M
Carcinogenesis; 1993 Dec; 14(12):2601-4. PubMed ID: 7903604
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by the calmodulin antagonist trifluoperazine of experimental hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.
Tatsuta M; Iishi H; Baba M; Yano H; Uehara H; Nakaizumi A; Iseki K
Cancer Lett; 1996 Oct; 107(2):179-85. PubMed ID: 8947510
[TBL] [Abstract][Full Text] [Related]
12. Suppression by pravastatin, an inhibitor of p21ras isoprenylation, of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.
Tatsuta M; Iishi H; Baba M; Iseki K; Yano H; Uehara H; Yamamoto R; Nakaizumi A
Br J Cancer; 1998 Feb; 77(4):581-7. PubMed ID: 9484815
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by verapamil of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.
Uehara H; Nakaizumi A; Baba M; Iishi H; Tatsuta M
Br J Cancer; 1993 Jul; 68(1):37-40. PubMed ID: 8100445
[TBL] [Abstract][Full Text] [Related]
14. Inhibition by d-limonene of experimental hepatocarcinogenesis in Sprague-Dawley rats does not involve p21(ras) plasma membrane association.
Kaji I; Tatsuta M; Iishi H; Baba M; Inoue A; Kasugai H
Int J Cancer; 2001 Aug; 93(3):441-4. PubMed ID: 11433412
[TBL] [Abstract][Full Text] [Related]
15. Suppression by Chai-hu-gui-zhi-tang of the development of liver lesions induced by N-nitrosomorpholine in Sprague-Dawley rats.
Tatsuta M; Iishi H; Baba M; Narahara H; Yano H; Sakai N
Cancer Lett; 2000 Apr; 152(1):31-6. PubMed ID: 10754203
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
